View drug registration information details.


ItemsRegistration information
ID1631
No1631
Brand NameARIMIDEX ANAR
IngredientsANASTROZOLE 1 MG
Dosage FormTABLET
Primary PackagingBLISTERPACK
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 10 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE OR HORMONE RECEPTOR UNKNOWN LOCALLY ADVANCED OR METASTATIC BREAST CANCER, ADJUVANT TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE EARLY BREAST CANCER, TREATMENT OF ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH DISEASE PROGRESSION FOLLOW TAMOXIFEN THERAPY
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionWHITE, ROUND TABLETS, PLAIN ON BOTH SIDES
Note
License OwnerLAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY
ManufacturerLAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No07 L 1131/24
FDD Registration Date12-JUL-2024
Expiry Date11-JUL-2027

Back to drug list